Effect of a DPP-4 inhibitor on vascular endothelial function in type 2 diabetic patients

Trial Profile

Effect of a DPP-4 inhibitor on vascular endothelial function in type 2 diabetic patients

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2012

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Jul 2012 Actual end date (Aug 2011) added as reported by University Hospital Medical Information Network - Japan record.
    • 09 Jun 2012 Planned end date (Aug 2011) added as reported by University Hospital Medical Information Network - Japan records.
    • 21 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top